NO960268L - Nye dialkoksypyridinylbenzimidazolderivater - Google Patents

Nye dialkoksypyridinylbenzimidazolderivater

Info

Publication number
NO960268L
NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
Authority
NO
Norway
Prior art keywords
compounds
methyl
new
dialkoxypyridinylbenzimidazole
derivatives
Prior art date
Application number
NO960268A
Other languages
English (en)
Norwegian (no)
Other versions
NO960268D0 (no
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Per Oskar Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO960268L publication Critical patent/NO960268L/no
Publication of NO960268D0 publication Critical patent/NO960268D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO960268A 1994-05-27 1996-01-23 Nye dialkoksypyridinylbenzimidazolderivater NO960268D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25617194A 1994-05-27 1994-05-27
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (2)

Publication Number Publication Date
NO960268L true NO960268L (no) 1996-01-23
NO960268D0 NO960268D0 (no) 1996-01-23

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960268A NO960268D0 (no) 1994-05-27 1996-01-23 Nye dialkoksypyridinylbenzimidazolderivater

Country Status (18)

Country Link
EP (1) EP0712401A1 (is)
JP (1) JPH09504557A (is)
CN (1) CN1128997A (is)
AU (1) AU2633095A (is)
BR (1) BR9506235A (is)
CA (1) CA2166988A1 (is)
CZ (1) CZ24396A3 (is)
EE (1) EE9600011A (is)
FI (1) FI960367A0 (is)
HU (1) HU9600005D0 (is)
IL (1) IL113604A0 (is)
IS (1) IS4321A (is)
MA (1) MA23563A1 (is)
NO (1) NO960268D0 (is)
PL (1) PL312692A1 (is)
TN (1) TNSN95062A1 (is)
WO (1) WO1995032959A1 (is)
ZA (1) ZA954125B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
BR9915421A (pt) * 1998-11-18 2001-08-07 Astrazeneca Ab Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3049367B2 (ja) * 1990-06-20 2000-06-05 アストラゼネカ・アクチエボラーグ ジアルコキシ−ピリジニル−ベンズイミダゾール誘導体、その製造方法およびそれを含む医薬
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
JPH09504557A (ja) 1997-05-06
AU2633095A (en) 1995-12-21
ZA954125B (en) 1995-11-27
MA23563A1 (fr) 1995-12-31
FI960367A (fi) 1996-01-26
EP0712401A1 (en) 1996-05-22
TNSN95062A1 (fr) 1996-02-06
IS4321A (is) 1996-01-17
PL312692A1 (en) 1996-05-13
NO960268D0 (no) 1996-01-23
BR9506235A (pt) 1997-08-12
HU9600005D0 (en) 1996-03-28
FI960367A0 (fi) 1996-01-26
WO1995032959A1 (en) 1995-12-07
EE9600011A (et) 1996-04-15
CN1128997A (zh) 1996-08-14
CZ24396A3 (en) 1996-06-12
IL113604A0 (en) 1995-08-31
CA2166988A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
MY121192A (en) New compounds.
NO960268L (no) Nye dialkoksypyridinylbenzimidazolderivater
NO160204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO171915C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azabicyklo(4.2.0)okt-2-en-derivater
IL57324A (en) 3-substituted-6-alkanoylamino-1,3,5-triazine-2,4-diones,process for their preparation and pharmaceutical compositions containing them
DE3767114D1 (de) Stabilisierte arzneimittel.
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
NO960267L (no) Nye substituerte benzimidazoler
ES8303418A1 (es) Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol.
JO1871B1 (en) Innovative substituted benzimidazole compounds
JO1870B1 (en) CO2 derivatives - pyridinyl benzimidazole innovative
EP0192393A3 (en) Alkylaminofuranone derivatives
FI893570A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi
AU617849B2 (en) New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE69000806T2 (de) Indol-derivate.
HUT42093A (en) Process for preparing 2-/2-thienyl/-imidazo/4,5-e/pyridine derivatives ang pharmaceutically acceptable acid addition salts thereof
DK210387A (da) Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse
JO1660B1 (en) Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them